The Bill & Melinda Gates Foundation is known for spending big money to fight infectious diseases in developing countries. While that's a noble cause, the foundation isn't afraid to invest elsewhere. Earlier this year, it invested $5 million in Smart Immune to develop a technique to turn stem cells into progenitor T-cells in the lab. Once injected, these cells mature in the body, differentiating between normal cells and threats, to rebuild the patient's immune system after chemotherapy treatment.
In the world of finance and taxation, a narrative has emerged that's caught the attention of many: the story of how some of the richest people, including Amazon.com Inc. Founder Jeff Bezos, Tesla Inc. CEO Elon Musk and Berkshire Hathaway Inc. CEO Warren Buffett, managed to significantly reduce their tax liabilities through the use of loopholes. These titans of industry have amassed immense wealth, and the question of how they navigate the complex tax landscape has become a subject of scrutiny an
/PRNewswire/ The oncology molecular diagnostics market size is expected to grow by USD 2.98 billion from 2022 to 2027. In addition, the momentum of the.
/PRNewswire/ The Global Oncology Drugs Market (2022-2027) by Drug Class, Indication, End-user, Geography, Competitive Analysis and the Impact of Covid-19.